J.J. Gout-Zwart, BSc

Research

Publications
  1. Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis

    de Jong, L. A., Gout-Zwart, J. J., van den Bosch, M., Koops, M. & Postma, M. J., 7-Jan-2019, In : Journal of Medical Economics. p. 1-29 29 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

    De Jong, L. A., Gout-Zwart, J. J., Stevanovic, J., Rila, H., Koops, M., Huisman, M. V. & Postma, M. J., 30-Dec-2018, In : BMJ Open. 2, 3, p. e315-e324 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Trends in direct oral anticoagulant (DOAC) use: Health benefits and patient preference

    de Jong, L. A., Koops, M., Gout-Zwart, J. J., Beinema, M. J., Hemels, M. E. W., Postma, M. J. & Brouwers, J. R. B. J., 1-Dec-2018, In : Netherlands Journal of Medicine. 76, 10, p. 426-430 5 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations

    Gout-Zwart, J. J., Olde Hengel, E. H. J., Hoogland, P. & Postma, M. J., Feb-2019, In : Applied Health Economics and Health Policy. 17, 1, p. 55-63 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Costs of clinical events in diabetes type 2 patients in The Netherlands: A systematic review

    Van Schoonhoven, A., De Vries, M., Gout-Zwart, J., Vemer, P., Van Boven, J., Dvortsin, E. & Postma, M. J., 1-Oct-2017, In : Value in Health. 20, 9, p. 485-486 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (9) »

View graph of relations

ID: 38980907